ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Near Infrared Optical Coherence Tomography of the Upper Aero-Digestive Tract

This study is enrolling participants by invitation only.

Sponsors and Collaborators: University of California, Irvine
Beckman Laser Institute Medical Clinic
Information provided by: University of California, Irvine
ClinicalTrials.gov Identifier: NCT00544427
  Purpose

At Beckman Laser Institute, University of California, Irvine, we have developed diagnostic device call 'Optical Coherence tomography (OCT)'.

OCT is an imaging technique capable of performing high-resolution,cross-sectional imaging. OCT enables real-time, in situ visualization of tissue microstructure without the need to excise and process the specimen as required for conventional biopsy and histopathology.

Optical coherence tomography (OCT) is an emerging imaging modality that uses light to image turbid media such as living tissues, and has been successfully used to generate high resolution cross-sectional images of tissue microstructure in the human retina and skin.

We have developed a multi-purpose OCT system for use in imaging the larynx, esophagus, trachea, oral cavity and nasal cavity with the overall objective of evaluating the efficacy of using OCT to image the microstructure of these organs. The OCT imaging system has image tissues of the aero-digestive tract during surgical endoscopy,the nose, oral cavity,larynx in an outpatient clinic setting. Knowledge of vocal cord, esophageal, tracheal, oral cavity, and nasal epithelial/mucosal microstructure would be extremely valuable in the treatment and diagnosis of both benign and malignant diseases of the upper aero-digestive tract, and at present there are no reliable techniques which provide this information with this degree of resolution other than a biopsy.


Condition Intervention
Upper Areo-Digestive Tract
Device: OCT

MedlinePlus related topics:   CT Scans  

U.S. FDA Resources

Study Type:   Observational
Study Design:   Case-Only, Prospective
Official Title:   Near Infrared Optical Coherence Tomography of the Upper Aero-Digestive Tract

Further study details as provided by University of California, Irvine:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment:   400
Study Start Date:   August 2003
Estimated Study Completion Date:   June 2012
Estimated Primary Completion Date:   June 2012 (Final data collection date for primary outcome measure)

Groups/Cohorts Assigned Interventions
1 Device: OCT
OCT

Detailed Description:

This study involves the collection of data through a noninvasive means in patients who are undergoing laryngeal, oral cavity, esophageal, tracheal, and nasal endoscopy for other medically indicated reasons. During laryngeal surgical endoscopy, the data obtained will not be used for patient care. Images will also be obtained using a surgical laryngoscope thru which an OCT imaging fiber is placed.

The device focuses low power non-laser broad band infrared light onto laryngeal, esophageal, tracheal, oral and nasal tissue and does not involve input of significant amounts of energy into the subject; no temperature rise occurs. In this respect, it is quite similar to other diagnostic imaging techniques as well as other UCI IRB approved protocols (at least one of which is approved as expedited) involving near-infrared light. Because there is no direct contact of the device with the subject, and because the wavelength of light used for imaging does not have adverse tissue effects, there is no increase in risk over and above the risk the subject already accepts while undergoing general anesthesia or sedation.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample

Study Population

Primary care clinic, and community population


Criteria

Inclusion Criteria:

  • Male and female age from new born to all age

Exclusion Criteria:

  • subject who do not sign consent form
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00544427

Locations
United States, California
Otolaryngology-Head and Neck Surgery Medical Clinic,University of California,Irvine    
      Orange, California, United States, 92898
Beckman Laser Institute medical Clinic,University of California,Irvine    
      Irvine, California, United States, 92612

Sponsors and Collaborators
University of California, Irvine
Beckman Laser Institute Medical Clinic

Investigators
Principal Investigator:     Brian JF Wong, M.D.,Ph.D.     Beckman Laser Institute Medical Clinic,University ofCalifornia,Irvine    
  More Information

Responsible Party:   Beckman Laser Institute ( Brian JF Wong, M.D.,Ph.D )
Study ID Numbers:   RR-01192, DC-06026, 12RT-0113, P41-RR01192;NIH-LAMMP
First Received:   October 12, 2007
Last Updated:   May 22, 2008
ClinicalTrials.gov Identifier:   NCT00544427
Health Authority:   United States: Institutional Review Board

Keywords provided by University of California, Irvine:
Upper Areo-Digestive tract  

ClinicalTrials.gov processed this record on July 03, 2008




Links to all studies - primarily for crawlers